×
News Home

Should You Accumulate Kazia Therapeutics Ltd (KZIA) Stock Monday Morning?

Monday, August 08, 2022 07:43 AM | InvestorsObserver Analysts
Should You Accumulate Kazia Therapeutics Ltd (KZIA) Stock Monday Morning?

Kazia Therapeutics Ltd (KZIA) is down Monday morning, with the stock declining -4.30% in pre-market trading to 1.78. KZIA's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 107 out of 146 industries, the stock ranks higher than 37% of stocks. Kazia Therapeutics Ltd has fallen 54.30% over the past month, closing at $3.97 on July 11. During this period of time, the stock fell as low as $1.76 and as high as $4.08. KZIA has an average analyst recommendation of Sell. The company has an average price target of $16.00.

Overall Score - 43
KZIA has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on KZIA!
Kazia Therapeutics Ltd has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 71 by this metric, KZIA ranks better than 71% of stocks.

Important Dates for Investors in KZIA:

-We do not have a set earnings date for Kazia Therapeutics Ltd at this time. -We do not have a set dividend date for Kazia Therapeutics Ltd at this time. Click Here To Get The Full Report on Kazia Therapeutics Ltd (KZIA)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App